KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Total Liabilities (2016 - 2025)

Johnson & Johnson's Total Liabilities history spans 17 years, with the latest figure at $117.7 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 8.33% year-over-year to $117.7 billion; the TTM value through Dec 2025 reached $117.7 billion, up 8.33%, while the annual FY2025 figure was $117.7 billion, 8.33% up from the prior year.
  • Total Liabilities for Q4 2025 was $117.7 billion at Johnson & Johnson, up from $113.5 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $125.1 billion in Q2 2023 and bottomed at $94.8 billion in Q4 2023.
  • The 5-year median for Total Liabilities is $108.6 billion (2024), against an average of $108.7 billion.
  • The largest annual shift saw Total Liabilities rose 20.7% in 2023 before it fell 18.51% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $109.0 billion in 2021, then decreased by 7.74% to $100.5 billion in 2022, then decreased by 1.73% to $98.8 billion in 2023, then increased by 9.95% to $108.6 billion in 2024, then increased by 8.33% to $117.7 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Total Liabilities are $117.7 billion (Q4 2025), $113.5 billion (Q3 2025), and $114.9 billion (Q2 2025).